The interplay between cancer genome and deregulated epigenomic control is critical for cancer initiation and progression. ASXL1 (Additional Sex combs-like 1) is frequently mutated in tumors especially myeloid malignancies. However. there remains a debate whether the mutations are loss or gain-of-function. https://www.campicon.com/